LEUKAEMIA
Clinical trials for LEUKAEMIA explained in plain language.
Never miss a new study
Get alerted when new LEUKAEMIA trials appear
Sign up with your email to follow new studies for LEUKAEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immune cell therapy takes on Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new treatment called EBNK-001, made from donor immune cells (natural killer cells), in people with advanced solid tumors that have not responded to standard therapies. Participants receive the cells after chemotherapy to prepare the body, along with low-dose in…
Matched conditions: LEUKAEMIA
Phase: PHASE1, PHASE2 • Sponsor: Essen Biotech • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Florida cancer patients get AI-Powered personalized treatment plans in new study
Knowledge-focused Recruiting nowThis study is testing whether a new tool called xDRIVE, which combines artificial intelligence and tumor profiling, can quickly suggest personalized treatment options for cancer patients in Florida whose cancer has come back or not responded to standard treatments. The goal is to…
Matched conditions: LEUKAEMIA
Phase: NA • Sponsor: First Ascent Biomedical Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
AI robot teaches patients about clinical trials – will it boost participation?
Knowledge-focused Recruiting nowThis study tests whether an AI-powered chatbot can help people with blood cancers like leukemia and lymphoma better understand clinical trials and feel more willing to join them. Researchers will compare patients who get standard education plus AI chatbot sessions to those who on…
Matched conditions: LEUKAEMIA
Phase: NA • Sponsor: Zhongnan Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC